konectar Description
konectar is an AI-powered KOL Management platform designed to solve one of the most persistent challenges in life sciences: knowing which healthcare professionals truly matter for your strategy, and how to engage them effectively.
Most KOL management approaches rely on manual research, internal nominations, or relationships inherited from predecessor teams. konectar replaces that patchwork with a structured, AI-powered intelligence layer, one that continuously analyses scientific output, clinical trial involvement, conference activity, peer networks, and digital presence to rank and profile HCPs across any therapeutic area.
The result is a platform that helps medical affairs and commercial teams move faster, engage more credibly, and build relationships that are rooted in scientific alignment rather than proximity or habit.
Key Features
* Rank and map KOLs across global, national, and regional levels with comprehensive 360-degree profiles.
* Real-time profile updates as HCPs publish, present, and participate in trials
* Conference monitoring and planning effective participation, conference intelligence with pre- and post-congress reports
* Social listening and DOL tracking via konectar Social
* Driving effective engagement with konectar CRM
konectar is used by pharma, biotech, and medtech teams across all company sizes and geographies.
Pricing
Integrations
Company Details
Product Details
konectar Features and Options
konectar Lists
konectar User Reviews
Write a Review-
Likelihood to Recommend to Others1 2 3 4 5 6 7 8 9 10
Best KOL Mapping Software Edited: Dec 06 2023
Summary: konectar is an all-inclusive platform, so you don't have to switch between different platforms for HCP insights, streamline engagement.
Positive: The konectar platform can be customized to your business needs, sales processes, or workflow. Moreover, it can be accessed from iPads, smartphones, and desktops.
Negative: I have no complaints; on the contrary, I consider it handy and well-designed SaaS based software.
Read More...
- Previous
- You're on page 1
- Next